Dr Andrew Hadley is Division Manager at the International Blood Group Reference Laboratory, and Senior Scientist at the Bristol Institute for Transfusion Sciences, University of Bristol.
Preface Andrew G. Hadley and Peter Soothill; 1. Pathophysiology of the
alloimmune cytopenias Andrew G. Hadley and Craig Turner; 2. Blood group
antibodies in haemolytic disease of the fetus and newborn Geoff Daniels; 3.
Basis and practice of screening for haemolytic disease of the fetus and
newborn Geoff Poole; 4. Epidemiology and screening for alloimmune
thrombocytopenia Lorna M. Williamson and Michael F. Murphy; 5. Principles
of antibody-mediated immune suppression and the prevention of maternal
Rh(D) alloimmunisation Belinda Kumpel; 6. The clinical application of
anti-D prophylaxis Stan Urbaniak; 7. Fetal genotyping Neil D. Avent; 8.
Laboratory assays to determine the severity of haemolytic disease of the
fetus and newborn Andrew G Hadley; 9. Assessing the severity of haemolytic
disease of the fetus and newborn: clinical aspects Sherif Abdel-Fattah and
Peter Soothill; 10. Antenatal therapy for haemolytic disease of the fetus
and newborn Kenneth J. Moise and Paul W. Whitecar; 11. Neonatal therapy for
haemolytic disease of the newborn Glynn Russell and Nic Goulden; 12. The
diagnosis of alloimmune thrombocytopenia Andrew Hadley; 13. The diagnosis
of alloimmune neutropenia Geoff Lucas; 14. Fetal and neonatal treatment of
alloimmune thrombocytopenia Michael Murphy, Rachel Rayment, David Allen and
David Roberts; Index.
